Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 33.15
+0.75 (2.31%)
At close: Aug 4, 2026
Hinova Pharmaceuticals Market Cap
Hinova Pharmaceuticals has a market cap or net worth of 3.28 billion as of August 4, 2026. Its market cap has decreased by -45.65% in one year.
Market Cap
3.28B
Enterprise Value
2.56B
Revenue
46.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.15
ChartMarket Cap Chart
Since April 12, 2022, Hinova Pharmaceuticals's market cap has increased from 2.98B to 3.28B, an increase of 10.13%. That is a compound annual growth rate of 2.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 3.28B | -32.58% |
| Dec 31, 2025 | 4.87B | 60.11% |
| Dec 31, 2024 | 3.04B | -41.02% |
| Dec 29, 2023 | 5.16B | 29.14% |
| Dec 30, 2022 | 3.99B | 33.95% |
| Apr 12, 2022 | 2.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Boji Medical Technology | 3.53B |
| Shanghai Obio Technology (Group) Corp. | 3.53B |
| Kexing Biopharm | 3.52B |
| Lifecome Biochemistry | 3.44B |
| Shanghai Shen Lian Biomedical | 3.39B |
| Jiangsu Bioperfectus Technologies | 3.28B |
| Baolingbao Biology | 3.05B |
| Shanghai Serum Bio-Technology | 2.97B |